News
$ABOS - Acumen Pharmaceuticals to Present Preliminary Baseline Characteristics and Data on Care Experiences and Participation in Phase 2 ALTITUDE-AD T
Oct 22, 2026 Ā· ThinkSabio Blog
$ABOS - Acumen Pharmaceuticals to Present Preliminary Baseline Characteristics and Data on Care Experiences and Participation in Phase 2 ALTITUDE-AD Trial at the 19th Annual Clinical Trials on Alzheimerās Disease (CTAD) Conference
22-OCT-2026 07:30 AM ET
Share this post
š¬ Comments
Loading commentsā¦
Leave a comment